AP ALEXION PHARMACEUTICALS INC Stock: price and insider trades · United States · SEC (Form 4)Track the ALEXION PHARMACEUTICALS INC share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 8 February 2016 (Attribution). Among the most active insiders: Sinha Vikas. Every trade is openly available.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 February 2016
All Executives101 Thresholds0 Prospectus0 Other0
Declarations 101 total
◆ EVP. Global Operations · Executives · 4 Feb 2016
11,763 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000238:0
▼ EVP. Global Operations · Executives · 5 Feb 2016
348 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000238:1
▼ EVP. Global Operations · Executives · 5 Feb 2016
352 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000238:2
▼ EVP. Global Operations · Executives · 5 Feb 2016
351 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000238:3
▼ EVP. Global Operations · Executives · 5 Feb 2016
499 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000238:4
▼ EVP. Global Operations · Executives · 5 Feb 2016
530 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000238:5
▼ EVP. Global Operations · Executives · 8 Feb 2016
23 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000238:6
▼ EVP. Global Operations · Executives · 8 Feb 2016
755 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000238:7
◆ EVP & Global Head of R&D · Executives · 4 Feb 2016
11,763 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000239:0
▼ EVP & Global Head of R&D · Executives · 5 Feb 2016
100 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000239:1
▼ EVP & Global Head of R&D · Executives · 5 Feb 2016
362 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000239:2
▼ EVP & Global Head of R&D · Executives · 5 Feb 2016
100 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000239:3
▼ EVP & Global Head of R&D · Executives · 5 Feb 2016
100 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000239:4
▼ EVP & Global Head of R&D · Executives · 5 Feb 2016
400 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000239:5
▼ EVP & Global Head of R&D · Executives · 5 Feb 2016
1,043 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000239:6
▼ EVP & Global Head of R&D · Executives · 8 Feb 2016
58 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000239:7
▼ EVP & Global Head of R&D · Executives · 8 Feb 2016
1,908 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000239:8
▼ EVP & CFO · Executives · 4 Feb 2016
692 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000240:0
▼ EVP & CFO · Executives · 4 Feb 2016
11 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000240:1
◆ EVP & CFO · Executives · 4 Feb 2016
11,763 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000240:2
▼ EVP & CFO · Executives · 5 Feb 2016
100 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000240:3
▼ EVP & CFO · Executives · 5 Feb 2016
300 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000240:4
▼ EVP & CFO · Executives · 5 Feb 2016
500 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000240:5
▼ EVP & CFO · Executives · 5 Feb 2016
200 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000240:6
▼ EVP & CFO · Executives · 5 Feb 2016
435 shares Common Stock, par value $.0001 per share SEC:0000899866-16-000240:7
25 of 101 declarations
Load more (76 remaining) 关于 ALEXION PHARMACEUTICALS INC ALEXION PHARMACEUTICALS INC 是一家生物制药公司，专注于开发罕见和严重疾病的治疗方法。它专门从事创新药物的研发和商业化，以改善患者的生活。